About the Corporate Partnership Programme

The Corporate Partnership Programme brings together non-industry and key IAS industry partners to drive important conversations across the HIV continuum of care.

In 2021, it expanded from the flagship Industry Liaison Forum to bring two additional groups under its umbrella – the Towards an HIV Cure: Industry Collaboration Group and the HIV Vaccine Industry Partnership Group. The expansion strengthens collaboration around specific pressing needs in the HIV response.

The Industry Liaison Forum convenes biomedical industry and non-industry stakeholders, including community-based organizations, on a broad range of topics relevant for the strong response of the pharmaceutical, diagnostics and other industry sectors to HIV.

The Towards an HIV Cure: Industry Collaboration Group aims to identify and prioritize ways for biomedical industry and non-industry stakeholders to work together in HIV cure research and development.

The HIV Vaccine Industry Partnership Group brings together the biomedical industry and non-industry stakeholders to address the complexities of HIV vaccine research and development.

Each group offers stakeholders opportunities to inform research agendas; explore (faster) ways to get new technologies to markets; and mobilize the biomedical industry and non-industry (academic, civil society and global health institutions) towards meeting the groups’ goals.

Visit our individual pages to find concrete case studies that show how membership could work for you:

Benefits of Corporate Partnership Programme membership

All members of the Corporate Partnership Programme receive prominent brand visibility on IAS digital platforms and at events. Members also have the chance to network and engage across the three groups and with other stakeholders.

Additional benefits:

• Engage with academic, civil society and global health institutions on a broad range of topics.
• Join a vibrant and productive environment to work together to advance new ideas and solutions.
• Contribute to and propose topics and agenda items for the programme’s yearly activities.
• Participate in thematic roundtables and quarterly calls.
• Get exclusive invitations to industry group networking events and meetings at the International AIDS Conference and the IAS Conference on HIV Science.
• Participate in the Corporate Partnership Programme’s annual members’ reception held at AIDS and IAS conferences.
• Meet the IAS Governing Council at AIDS and IAS conferences.
• Gain brand visibility on the Corporate Partnership Programme webpage and in relevant publications.

Corporate Partnership Programme partners

The IAS would like to thank its 2022 Corporate Partners: